The Insurance Regulatory is said to have withdrawn the draft guidelines it issued on a standard COVID-19 health insurance product earlier in June and has instead proposed a benefit-based product. We review the new proposed product to help you understand what it is and whether you should go for it.
The Website uses cookies to ensure you get the best experience on our website. If you continue browsing you will be providing your consent to our use of these.